PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Its association is most pronounced in Hispanics, indicating interactions with other genomic loci, and more than 20% of the population carries the risk allele, so the collective effect of PNPLA3 on NAFLD is high [51].